Clinical Trial Update: 2nd Line Erlotinib Treatment With (Out) Chemotherapy of Advanced Non Small Cell Lung Cancer (NSCLC) [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating erlotinib with or without chemotherapy in advanced non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• ERLOTINIB (Erlotinib)

Snippet

Sponsor: Dutch Society of Physicians for Pulmonology and Tuberculosis | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 2 | Status: COMPLETED